Archicare Limited
Gliclazide (80mg) + Metformin (500mg)
Glycocare M 80mg/500mg Tablet is a combination of two medicines used to treat type 2 diabetes mellitus in adults.
Tablet
Glycocare M 80mg/500mg Tablet is a combination of two antidiabetic medicines: Gliclazide and Metformin. It is used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glycocare M 80mg/500mg Tablet is to be taken with food.
No common side effects listed.
It is unsafe to consume alcohol with Glycocare M 80mg/500mg Tablet.
Glycocare M 80mg/500mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glycocare M 80mg/500mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Glycocare M 80mg/500mg Tablet is a combination of two antidiabetic medicines: Gliclazide and Metformin.
Monitor your blood sugar level regularly while you are taking this medicine. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic. Tell your doctor immediately if you experience any deep or rapid breathing or if you have persistent nausea Your doctor may check your liver function regularly.
Glycocare M 80mg/500mg Tablet is a combination of two medicines: Gliclazide and Metformin. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken along with proper diet and regular exercise. Gliclazide lowers blood glucose levels by increasing insulin release from the pancreas. Metformin works by lowering glucose production in the liver and improving insulin sensitivity.
The use of Glycocare M 80mg/500mg Tablet is associated with common side effects. These may include hypoglycemia (low blood sugar), altered taste, nausea, stomach pain, diarrhea, headache and upper respiratory tract infection. It can also lead to serious but rare side effects such as lactic acidosis.
Yes, the use of Glycocare M 80mg/500mg Tablet can cause hypoglycemia (low blood sugar). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate and feeling anxious or shaky. It is more likely to occur if you miss meals, drink alcohol, exercise excessively, or take other diabetes medication concurrently.
Yes, the use of Glycocare M 80mg/500mg Tablet can lead to lactic acidosis. This is a medical emergency caused by increased levels of lactic acid in the blood. It is associated with metformin and should be avoided if you have underlying kidney disease or are on high doses of alcohol.
Yes, prolonged use of Glycocare M 80mg/500mg Tablet can lead to vitamin B12 deficiency. This is because the medication interferes with vitamin B12 absorption in the stomach. Untreated vitamin B12 deficiency can result in anemia and nerve problems.
Glycocare M 80mg/500mg Tablet is generally safe for most people with type 2 diabetes. However, it should be avoided if you have known allergies to any of the ingredients or excipients of this medication. Additionally, it should not be used in those with: moderate to severe kidney disease or underlying metabolic acidosis including diabetic ketoacidosis.
No, it is not advisable to take alcohol while you are on Glycocare M 80mg/500mg tablet. Alcohol can lower your blood sugar levels and increase the chances of lactic acidosis.
Glycocare M 80mg/500mg Tablet is a combination of two medicines: Gliclazide and Metformin. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken along with proper diet and regular exercise. Gliclazide lowers blood glucose levels by increasing insulin release from the pancreas. Metformin works by lowering glucose production in the liver and improving insulin sensitivity.